USPTO serial 88735791
BUMBLE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 30, 2026
- Examiner
- PINO, DOMINIC ROBERT
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BUMBLE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Winfield B. Martin
Winfield B. Martin Perkins Coie LLPP.O. Box 2608Seattle, WA 98111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, namely, antibacterial pharmaceuticals, ocular pharmaceuticals, pharmaceuticals for the treatment of viral infections, pharmaceuticals for the treatment of viral diseases, therapeutic pharmaceuticals for the treatment of sexually transmitted infections, pharmaceuticals for the treatment of hormonal disorders, injectable contraceptives, inducers of erections, effervescent analgesic pharmaceutical preparations, bismuth preparations for pharmaceutical purposes, anti-infectives, royal jelly for pharmaceutical purposes, pharmaceutical preparations for treating sunburn, pharmaceutical preparations for skin care, balms for pharmaceutical purposes, pharmaceutical skin lotions, anti-diabetic pharmaceuticals, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations for treating chemical imbalances, pharmaceutical agents affecting sensory organs, pharmaceutical agents affecting metabolism, analgesic and muscle relaxant pharmaceutical preparations, pharmaceutical preparations for treating dandruff; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; medical preparations, namely, diagnostic preparations for medical purposes; medical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; veterinary preparations, namely, antioxidants and diagnostic preparations for veterinary purposes; veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic foods adapted for medical or veterinary use; medical plasters; material for dressings, namely, wading for dressings; medicated lotions and creams, namely, anti-fly lotion, medicated hair lotions, calamine lotions, medicated after-shave lotions, sports cream for relief of pain, medical creams for skin care, orgasm creams, topical analgesic creams, anti-itch creams, antibiotic creams, creams for dermatological use, and medicated cream soap; antiseptic creams, medicated diaper nappy-rash creams, medicated preparations for the care of sunburn; material for stopping teeth, dental wax; disinfectants; fungicides, herbicides; personal sexual lubricants; sexual stimulant gels; sanitary preparations for medical use; hand sanitizers; none of the aforesaid being products which contain ingredients derived from bees | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 30, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 30, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 12, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 12, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 6, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 15, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 9, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 1, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 1, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 1, 2026 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Apr 1, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 1, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 1, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 1, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 30, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 30, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 30, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 30, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 30, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 30, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 9, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 9, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 9, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 25, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 25, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 30, 2025 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 30, 2025 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 30, 2025 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 29, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 25, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 25, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 25, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 13, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 13, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 13, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 10, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 10, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 9, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 27, 2024 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Feb 27, 2024 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Feb 27, 2024 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 23, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 22, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 22, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 22, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 21, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 6, 2023 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jun 6, 2023 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jun 6, 2023 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 22, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 15, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 15, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 15, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 14, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 14, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 11, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 15, 2022 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jun 15, 2022 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jun 15, 2022 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Dec 8, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 8, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 8, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 7, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 7, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 7, 2021 | ALIE | ASSIGNED TO LIE | — |
| Dec 2, 2021 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 16, 2021 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jun 16, 2021 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jun 16, 2021 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 28, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 28, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 28, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 24, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 24, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 24, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 7, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 7, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 7, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 31, 2019 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 30, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 24, 2019 | NWAP | NEW APPLICATION ENTERED | — |